The Rubenstein Award is an annual accolade established in 2019 to recognize the contributions of leading pancreatic cancer researchers from outside Memorial Sloan Kettering Cancer Center.
Past honorees have made trailblazing discoveries and participated in some of the field’s most important clinical trials. Among other accomplishments, their work has brought forth the first chemotherapy approved for pancreatic cancer, established the first laboratory models of pancreatic cancer, and yielded new approaches to immunotherapy.
2019 Awardee
National Foundation for Cancer Research
2020 Awardee
Johns Hopkins Medicine
2021 Awardee
Cold Spring Harbor Laboratory
2022 Awardee
Gloria M. Peterson, PhD
2023 Awardee
University of California, San Diego